Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-22-024711

Chief Medical Officer acquired 622 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sachs Jessica Chief Medical Officer 2022-06-30 Grant or award +622 $7.40 $4,600 622 D
Loading xslF345X03/doc4.xml…